PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40121C00137AREA of NEED: DRUG development for — Children'S Hospital of Philadelphia, the

Children'S Hospital of Philadelphia, the holds $871K across 24 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 7, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
Children'S Hospital of Philadelphia, the
Recipient
Sep 7, 2026
PoP end
$1M
Obligated
$1M
Potential
541714
NAICS
AN11
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Children'S Hospital of Philadelphia, the — $90

Contract facts

NONE
Contract number75F40121C00137
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentChildren'S Hospital of Philadelphia, the
CAGE0GXU0
UEIG7MQPLSUX1L4
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11
Place of performanceSILVER SPRING MD
Pricing typeCost No Fee
Extent competedFull And Open Competition
Related solicitationFDABAA-21-00123
PoP startSep 8, 2021
PoP end (current)Sep 7, 2026
Obligated$1M
Current value$1M
Potential value$1M

AREA OF NEED: DRUG DEVELOPMENT FOR PEDIATRIC CANCERS HAS HISTORICALLY LAGGED FAR BEHIND ADULT CANCERS, AND MOSTLY RELIED ON A ?TRICKLE DOWN? EFFECT FROM ADULT ONCOLOGY. FURTHERMORE, THERE IS OFTEN A GAP OF 5-10 YEARS BETWEEN ADULT AND PEDIATRIC APP is a federal NONE award for Fda Office Of Acq Grant Svcs held by Children'S Hospital of Philadelphia, the. Estimated value $1M ($1M obligated). Current period of performance ends Sep 7, 2026. Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation FDABAA-21-00123.

AREA OF NEED: DRUG DEVELOPMENT FOR PEDIATRIC CANCERS HAS HISTORICALLY LAGGED FAR BEHIND ADULT CANCERS, AND MOSTLY RELIED ON A ?TRICKLE DOWN? EFFECT FROM ADULT ONCOLOGY. FURTHERMORE, THERE IS OFTEN A GAP OF 5-10 YEARS BETWEEN ADULT AND PEDIATRIC APP

Recompete timing

Public
Past PoP end (0 days ago)

Current PoP ends Sep 7, 2026 (0 days remaining). Agencies typically plan 12–18 months ahead — at 0.0 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Children'S Hospital of Philadelphia, the$871K obligated across 24 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($871K) · all agencies
Department of Health and Human Services (HHS)$544K · 62%
Consumer Product Safety Commission (CPSC)$199K · 23%
Department of Transportation (DOT)$128K · 15%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40121C00137?

75F40121C00137 (AREA of NEED: DRUG development for) is a Fda Office Of Acq Grant Svcs award with a potential value of $1M, currently held by Children'S Hospital of Philadelphia, the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40121C00137?

Fda Office Of Acq Grant Svcs awarded 75F40121C00137 to Children'S Hospital of Philadelphia, the (potential $1M).

Who is the incumbent on 75F40121C00137?

Children'S Hospital of Philadelphia, the is the incumbent with $871K across 24 related awards in SCOUT’s public footprint. The current period of performance ends Sep 7, 2026.

When does Children'S Hospital of Philadelphia, the’s 75F40121C00137 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 7, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40121C00137 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40121C00137